Davide Tampellini

6.6k total citations
31 papers, 3.3k citations indexed

About

Davide Tampellini is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Davide Tampellini has authored 31 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 18 papers in Cellular and Molecular Neuroscience and 12 papers in Neurology. Recurrent topics in Davide Tampellini's work include Alzheimer's disease research and treatments (19 papers), Neuroscience and Neuropharmacology Research (12 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Davide Tampellini is often cited by papers focused on Alzheimer's disease research and treatments (19 papers), Neuroscience and Neuropharmacology Research (12 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Davide Tampellini collaborates with scholars based in United States, Italy and France. Davide Tampellini's co-authors include Gunnar K. Gouras, Luigi Zecca, Estibaliz Capetillo‐Zarate, Reisuke H. Takahashi, Michael T. Lin, Peter Riederer, Ruggero G. Fariello, David Sulzer, Alberto Gatti and Mario Gallorini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Davide Tampellini

31 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Tampellini United States 25 1.5k 1.1k 1.1k 895 672 31 3.3k
Reidun Torp Norway 30 1.4k 1.0× 1.9k 1.7× 1.8k 1.6× 902 1.0× 745 1.1× 56 4.0k
John J. LaFrancois United States 24 2.6k 1.8× 1.4k 1.2× 1.4k 1.3× 453 0.5× 608 0.9× 36 4.5k
Manuela Polydoro United States 23 1.9k 1.3× 960 0.9× 926 0.9× 514 0.6× 753 1.1× 28 3.2k
Yazi D. Ke Australia 28 2.6k 1.8× 1.4k 1.2× 1.6k 1.5× 781 0.9× 850 1.3× 57 4.2k
Susan Leight United States 19 2.2k 1.5× 953 0.9× 1.2k 1.1× 1.5k 1.7× 795 1.2× 21 3.9k
Bess Frost United States 20 1.8k 1.2× 699 0.6× 1.7k 1.6× 532 0.6× 761 1.1× 40 3.3k
Sarah L. DeVos United States 22 2.6k 1.8× 1.1k 1.0× 1.6k 1.5× 714 0.8× 1.1k 1.7× 24 3.9k
Janet van Eersel Australia 17 1.8k 1.3× 980 0.9× 918 0.8× 364 0.4× 534 0.8× 24 2.6k
Margarita Carmona Spain 35 1.4k 1.0× 769 0.7× 1.3k 1.2× 707 0.8× 805 1.2× 60 3.1k
Valérie Buée‐Scherrer France 23 2.0k 1.4× 870 0.8× 1.4k 1.3× 589 0.7× 741 1.1× 42 3.5k

Countries citing papers authored by Davide Tampellini

Since Specialization
Citations

This map shows the geographic impact of Davide Tampellini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Tampellini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Tampellini more than expected).

Fields of papers citing papers by Davide Tampellini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Tampellini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Tampellini. The network helps show where Davide Tampellini may publish in the future.

Co-authorship network of co-authors of Davide Tampellini

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Tampellini. A scholar is included among the top collaborators of Davide Tampellini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Tampellini. Davide Tampellini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cascella, Roberta, Martina Banchelli, Seyyed Abolghasem Ghadami, et al.. (2022). An in situ and in vitro investigation of cytoplasmic TDP-43 inclusions reveals the absence of a clear amyloid signature. Annals of Medicine. 55(1). 72–88. 4 indexed citations
2.
Akwa, Yvette, Chiara Di Malta, Elise Gondard, et al.. (2022). Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies. Autophagy. 19(2). 660–677. 16 indexed citations
3.
Mann, Amandeep, Elise Gondard, Davide Tampellini, et al.. (2017). Chronic deep brain stimulation in an Alzheimer's disease mouse model enhances memory and reduces pathological hallmarks. Brain stimulation. 11(2). 435–444. 64 indexed citations
4.
Tampellini, Davide. (2015). Synaptic activity and Alzheimer's disease: a critical update. Frontiers in Neuroscience. 9. 423–423. 86 indexed citations
5.
Dumont, Magali, Cliona Stack, Ceyhan Elipenahli, et al.. (2012). Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice. Human Molecular Genetics. 21(23). 5091–5105. 64 indexed citations
6.
Tampellini, Davide, et al.. (2011). Impaired β-Amyloid Secretion in Alzheimer's Disease Pathogenesis. Journal of Neuroscience. 31(43). 15384–15390. 34 indexed citations
7.
Tampellini, Davide & Gunnar K. Gouras. (2011). Analysis of Vesicular Trafficking in Primary Neurons by Live Imaging. Methods in molecular biology. 793. 343–350. 4 indexed citations
8.
Capetillo‐Zarate, Estibaliz, Luis Gracia, Fangmin Yu, et al.. (2011). High-Resolution 3D Reconstruction Reveals Intra-Synaptic Amyloid Fibrils. American Journal Of Pathology. 179(5). 2551–2558. 30 indexed citations
9.
Tampellini, Davide, Estibaliz Capetillo‐Zarate, Magali Dumont, et al.. (2010). Effects of Synaptic Modulation on β-Amyloid, Synaptophysin, and Memory Performance in Alzheimer's Disease Transgenic Mice. Journal of Neuroscience. 30(43). 14299–14304. 118 indexed citations
10.
Tampellini, Davide. (2010). Synapses, synaptic activity and intraneuronal Aβ in Alzheimer’s disease. Frontiers in Aging Neuroscience. 2. 49 indexed citations
11.
Ma, Tao, Charles A. Hoeffer, Estibaliz Capetillo‐Zarate, et al.. (2010). Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease. PLoS ONE. 5(9). e12845–e12845. 214 indexed citations
12.
Dumont, Magali, Elizabeth Wille, Noel Y. Calingasan, et al.. (2009). Triterpenoid CDDO‐methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease. Journal of Neurochemistry. 109(2). 502–512. 95 indexed citations
13.
Tampellini, Davide, Jordi Magrané, Reisuke H. Takahashi, et al.. (2007). Internalized Antibodies to the Aβ Domain of APP Reduce Neuronal Aβ and Protect against Synaptic Alterations. Journal of Biological Chemistry. 282(26). 18895–18906. 99 indexed citations
14.
Almeida, Cláudia G., Davide Tampellini, Reisuke H. Takahashi, et al.. (2005). Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiology of Disease. 20(2). 187–198. 329 indexed citations
15.
Zecca, Luigi, Daniela Berg, Thomas Arzberger, et al.. (2005). In vivo detection of iron and neuromelanin by transcranial sonography: A new approach for early detection of substantia nigra damage. Movement Disorders. 20(10). 1278–1285. 176 indexed citations
16.
Zecca, Luigi, Fabio A. Zucca, Davide Tampellini, et al.. (2003). The neuromelanin of human substantia nigra: structure, synthesis and molecular behaviour. Journal of neural transmission. Supplementum. 145–155. 40 indexed citations
17.
Zecca, Luigi, Davide Tampellini, Alberto Gatti, et al.. (2002). The neuromelanin of human substantia nigra and its interaction with metals. Journal of Neural Transmission. 109(5-6). 663–672. 69 indexed citations
18.
Zecca, Luigi, Ruggero G. Fariello, Peter Riederer, et al.. (2001). The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Letters. 510(3). 216–220. 221 indexed citations
19.
Zecca, Luigi, Mario Gallorini, Volker Schünemann, et al.. (2001). Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. Journal of Neurochemistry. 76(6). 1766–1773. 326 indexed citations
20.
Bridelli, Maria Grazia, Davide Tampellini, & Luigi Zecca. (1999). The structure of neuromelanin and its iron binding site studied by infrared spectroscopy. FEBS Letters. 457(1). 18–22. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reidun Torp Breakdown of academic impact, for papers by John J. LaFrancois Breakdown of academic impact, for papers by Manuela Polydoro Breakdown of academic impact, for papers by Yazi D. Ke Breakdown of academic impact, for papers by Susan Leight Breakdown of academic impact, for papers by Bess Frost Breakdown of academic impact, for papers by Sarah L. DeVos Breakdown of academic impact, for papers by Janet van Eersel Breakdown of academic impact, for papers by Margarita Carmona Breakdown of academic impact, for papers by Valérie Buée‐Scherrer
Rankless by CCL
2026